Global Cancer Gene Therapy Market Research Report 2024, Forecast to 2032
Report Overview
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.
The global Cancer Gene Therapy market size was estimated at USD 522 million in 2023 and is projected to reach USD 2280.23 million by 2032, exhibiting a CAGR of 17.80% during the forecast period.
North America Cancer Gene Therapy market size was estimated at USD 180.69 million in 2023, at a CAGR of 15.26% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Cancer Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cancer Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cancer Gene Therapy market in any manner.
Global Cancer Gene Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Adaptimmune
Bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Altor BioScience
Amgen
Argenx
BioCancell
GlaxoSmithKline
Merck
OncoGenex Pharmaceuticals
Transgene
Market Segmentation (by Type)
Oncolytic Virotherapy
Gene Transfer
Gene-Induced Immunotherapy
Market Segmentation (by Application)
Hospitals
Diagnostics Centers
Research Institutes
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cancer Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.
The global Cancer Gene Therapy market size was estimated at USD 522 million in 2023 and is projected to reach USD 2280.23 million by 2032, exhibiting a CAGR of 17.80% during the forecast period.
North America Cancer Gene Therapy market size was estimated at USD 180.69 million in 2023, at a CAGR of 15.26% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Cancer Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cancer Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cancer Gene Therapy market in any manner.
Global Cancer Gene Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Adaptimmune
Bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Altor BioScience
Amgen
Argenx
BioCancell
GlaxoSmithKline
Merck
OncoGenex Pharmaceuticals
Transgene
Market Segmentation (by Type)
Oncolytic Virotherapy
Gene Transfer
Gene-Induced Immunotherapy
Market Segmentation (by Application)
Hospitals
Diagnostics Centers
Research Institutes
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Cancer Gene Therapy Market
- Overview of the regional outlook of the Cancer Gene Therapy Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cancer Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cancer Gene Therapy
1.2 Key Market Segments
1.2.1 Cancer Gene Therapy Segment by Type
1.2.2 Cancer Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANCER GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cancer Gene Therapy Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Cancer Gene Therapy Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANCER GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Cancer Gene Therapy Sales by Manufacturers (2019-2024)
3.2 Global Cancer Gene Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cancer Gene Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cancer Gene Therapy Sales Sites, Area Served, Product Type
3.6 Cancer Gene Therapy Market Competitive Situation and Trends
3.6.1 Cancer Gene Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cancer Gene Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CANCER GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Cancer Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANCER GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CANCER GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Gene Therapy Sales Market Share by Type (2019-2024)
6.3 Global Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Cancer Gene Therapy Price by Type (2019-2024)
7 CANCER GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Gene Therapy Market Sales by Application (2019-2024)
7.3 Global Cancer Gene Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Cancer Gene Therapy Sales Growth Rate by Application (2019-2024)
8 CANCER GENE THERAPY MARKET CONSUMPTION BY REGION
8.1 Global Cancer Gene Therapy Sales by Region
8.1.1 Global Cancer Gene Therapy Sales by Region
8.1.2 Global Cancer Gene Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Cancer Gene Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cancer Gene Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cancer Gene Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cancer Gene Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cancer Gene Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 CANCER GENE THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Cancer Gene Therapy by Region (2019-2024)
9.2 Global Cancer Gene Therapy Revenue Market Share by Region (2019-2024)
9.3 Global Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Cancer Gene Therapy Production
9.4.1 North America Cancer Gene Therapy Production Growth Rate (2019-2024)
9.4.2 North America Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Cancer Gene Therapy Production
9.5.1 Europe Cancer Gene Therapy Production Growth Rate (2019-2024)
9.5.2 Europe Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Cancer Gene Therapy Production (2019-2024)
9.6.1 Japan Cancer Gene Therapy Production Growth Rate (2019-2024)
9.6.2 Japan Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Cancer Gene Therapy Production (2019-2024)
9.7.1 China Cancer Gene Therapy Production Growth Rate (2019-2024)
9.7.2 China Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Adaptimmune
10.1.1 Adaptimmune Cancer Gene Therapy Basic Information
10.1.2 Adaptimmune Cancer Gene Therapy Product Overview
10.1.3 Adaptimmune Cancer Gene Therapy Product Market Performance
10.1.4 Adaptimmune Business Overview
10.1.5 Adaptimmune Cancer Gene Therapy SWOT Analysis
10.1.6 Adaptimmune Recent Developments
10.2 Bluebird bio
10.2.1 Bluebird bio Cancer Gene Therapy Basic Information
10.2.2 Bluebird bio Cancer Gene Therapy Product Overview
10.2.3 Bluebird bio Cancer Gene Therapy Product Market Performance
10.2.4 Bluebird bio Business Overview
10.2.5 Bluebird bio Cancer Gene Therapy SWOT Analysis
10.2.6 Bluebird bio Recent Developments
10.3 Celgene
10.3.1 Celgene Cancer Gene Therapy Basic Information
10.3.2 Celgene Cancer Gene Therapy Product Overview
10.3.3 Celgene Cancer Gene Therapy Product Market Performance
10.3.4 Celgene Cancer Gene Therapy SWOT Analysis
10.3.5 Celgene Business Overview
10.3.6 Celgene Recent Developments
10.4 Shanghai Sunway Biotech
10.4.1 Shanghai Sunway Biotech Cancer Gene Therapy Basic Information
10.4.2 Shanghai Sunway Biotech Cancer Gene Therapy Product Overview
10.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Product Market Performance
10.4.4 Shanghai Sunway Biotech Business Overview
10.4.5 Shanghai Sunway Biotech Recent Developments
10.5 Shenzhen SiBiono GeneTech
10.5.1 Shenzhen SiBiono GeneTech Cancer Gene Therapy Basic Information
10.5.2 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Overview
10.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Market Performance
10.5.4 Shenzhen SiBiono GeneTech Business Overview
10.5.5 Shenzhen SiBiono GeneTech Recent Developments
10.6 SynerGene Therapeutics
10.6.1 SynerGene Therapeutics Cancer Gene Therapy Basic Information
10.6.2 SynerGene Therapeutics Cancer Gene Therapy Product Overview
10.6.3 SynerGene Therapeutics Cancer Gene Therapy Product Market Performance
10.6.4 SynerGene Therapeutics Business Overview
10.6.5 SynerGene Therapeutics Recent Developments
10.7 Altor BioScience
10.7.1 Altor BioScience Cancer Gene Therapy Basic Information
10.7.2 Altor BioScience Cancer Gene Therapy Product Overview
10.7.3 Altor BioScience Cancer Gene Therapy Product Market Performance
10.7.4 Altor BioScience Business Overview
10.7.5 Altor BioScience Recent Developments
10.8 Amgen
10.8.1 Amgen Cancer Gene Therapy Basic Information
10.8.2 Amgen Cancer Gene Therapy Product Overview
10.8.3 Amgen Cancer Gene Therapy Product Market Performance
10.8.4 Amgen Business Overview
10.8.5 Amgen Recent Developments
10.9 Argenx
10.9.1 Argenx Cancer Gene Therapy Basic Information
10.9.2 Argenx Cancer Gene Therapy Product Overview
10.9.3 Argenx Cancer Gene Therapy Product Market Performance
10.9.4 Argenx Business Overview
10.9.5 Argenx Recent Developments
10.10 BioCancell
10.10.1 BioCancell Cancer Gene Therapy Basic Information
10.10.2 BioCancell Cancer Gene Therapy Product Overview
10.10.3 BioCancell Cancer Gene Therapy Product Market Performance
10.10.4 BioCancell Business Overview
10.10.5 BioCancell Recent Developments
10.11 GlaxoSmithKline
10.11.1 GlaxoSmithKline Cancer Gene Therapy Basic Information
10.11.2 GlaxoSmithKline Cancer Gene Therapy Product Overview
10.11.3 GlaxoSmithKline Cancer Gene Therapy Product Market Performance
10.11.4 GlaxoSmithKline Business Overview
10.11.5 GlaxoSmithKline Recent Developments
10.12 Merck
10.12.1 Merck Cancer Gene Therapy Basic Information
10.12.2 Merck Cancer Gene Therapy Product Overview
10.12.3 Merck Cancer Gene Therapy Product Market Performance
10.12.4 Merck Business Overview
10.12.5 Merck Recent Developments
10.13 OncoGenex Pharmaceuticals
10.13.1 OncoGenex Pharmaceuticals Cancer Gene Therapy Basic Information
10.13.2 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Overview
10.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Market Performance
10.13.4 OncoGenex Pharmaceuticals Business Overview
10.13.5 OncoGenex Pharmaceuticals Recent Developments
10.14 Transgene
10.14.1 Transgene Cancer Gene Therapy Basic Information
10.14.2 Transgene Cancer Gene Therapy Product Overview
10.14.3 Transgene Cancer Gene Therapy Product Market Performance
10.14.4 Transgene Business Overview
10.14.5 Transgene Recent Developments
11 CANCER GENE THERAPY MARKET FORECAST BY REGION
11.1 Global Cancer Gene Therapy Market Size Forecast
11.2 Global Cancer Gene Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cancer Gene Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Cancer Gene Therapy Market Size Forecast by Region
11.2.4 South America Cancer Gene Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Cancer Gene Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Cancer Gene Therapy Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Cancer Gene Therapy by Type (2025-2032)
12.1.2 Global Cancer Gene Therapy Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Cancer Gene Therapy by Type (2025-2032)
12.2 Global Cancer Gene Therapy Market Forecast by Application (2025-2032)
12.2.1 Global Cancer Gene Therapy Sales (K Units) Forecast by Application
12.2.2 Global Cancer Gene Therapy Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cancer Gene Therapy
1.2 Key Market Segments
1.2.1 Cancer Gene Therapy Segment by Type
1.2.2 Cancer Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANCER GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cancer Gene Therapy Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Cancer Gene Therapy Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANCER GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Cancer Gene Therapy Sales by Manufacturers (2019-2024)
3.2 Global Cancer Gene Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cancer Gene Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cancer Gene Therapy Sales Sites, Area Served, Product Type
3.6 Cancer Gene Therapy Market Competitive Situation and Trends
3.6.1 Cancer Gene Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cancer Gene Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CANCER GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Cancer Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANCER GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CANCER GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Gene Therapy Sales Market Share by Type (2019-2024)
6.3 Global Cancer Gene Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Cancer Gene Therapy Price by Type (2019-2024)
7 CANCER GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Gene Therapy Market Sales by Application (2019-2024)
7.3 Global Cancer Gene Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Cancer Gene Therapy Sales Growth Rate by Application (2019-2024)
8 CANCER GENE THERAPY MARKET CONSUMPTION BY REGION
8.1 Global Cancer Gene Therapy Sales by Region
8.1.1 Global Cancer Gene Therapy Sales by Region
8.1.2 Global Cancer Gene Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Cancer Gene Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cancer Gene Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cancer Gene Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cancer Gene Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cancer Gene Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 CANCER GENE THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Cancer Gene Therapy by Region (2019-2024)
9.2 Global Cancer Gene Therapy Revenue Market Share by Region (2019-2024)
9.3 Global Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Cancer Gene Therapy Production
9.4.1 North America Cancer Gene Therapy Production Growth Rate (2019-2024)
9.4.2 North America Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Cancer Gene Therapy Production
9.5.1 Europe Cancer Gene Therapy Production Growth Rate (2019-2024)
9.5.2 Europe Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Cancer Gene Therapy Production (2019-2024)
9.6.1 Japan Cancer Gene Therapy Production Growth Rate (2019-2024)
9.6.2 Japan Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Cancer Gene Therapy Production (2019-2024)
9.7.1 China Cancer Gene Therapy Production Growth Rate (2019-2024)
9.7.2 China Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Adaptimmune
10.1.1 Adaptimmune Cancer Gene Therapy Basic Information
10.1.2 Adaptimmune Cancer Gene Therapy Product Overview
10.1.3 Adaptimmune Cancer Gene Therapy Product Market Performance
10.1.4 Adaptimmune Business Overview
10.1.5 Adaptimmune Cancer Gene Therapy SWOT Analysis
10.1.6 Adaptimmune Recent Developments
10.2 Bluebird bio
10.2.1 Bluebird bio Cancer Gene Therapy Basic Information
10.2.2 Bluebird bio Cancer Gene Therapy Product Overview
10.2.3 Bluebird bio Cancer Gene Therapy Product Market Performance
10.2.4 Bluebird bio Business Overview
10.2.5 Bluebird bio Cancer Gene Therapy SWOT Analysis
10.2.6 Bluebird bio Recent Developments
10.3 Celgene
10.3.1 Celgene Cancer Gene Therapy Basic Information
10.3.2 Celgene Cancer Gene Therapy Product Overview
10.3.3 Celgene Cancer Gene Therapy Product Market Performance
10.3.4 Celgene Cancer Gene Therapy SWOT Analysis
10.3.5 Celgene Business Overview
10.3.6 Celgene Recent Developments
10.4 Shanghai Sunway Biotech
10.4.1 Shanghai Sunway Biotech Cancer Gene Therapy Basic Information
10.4.2 Shanghai Sunway Biotech Cancer Gene Therapy Product Overview
10.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Product Market Performance
10.4.4 Shanghai Sunway Biotech Business Overview
10.4.5 Shanghai Sunway Biotech Recent Developments
10.5 Shenzhen SiBiono GeneTech
10.5.1 Shenzhen SiBiono GeneTech Cancer Gene Therapy Basic Information
10.5.2 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Overview
10.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Market Performance
10.5.4 Shenzhen SiBiono GeneTech Business Overview
10.5.5 Shenzhen SiBiono GeneTech Recent Developments
10.6 SynerGene Therapeutics
10.6.1 SynerGene Therapeutics Cancer Gene Therapy Basic Information
10.6.2 SynerGene Therapeutics Cancer Gene Therapy Product Overview
10.6.3 SynerGene Therapeutics Cancer Gene Therapy Product Market Performance
10.6.4 SynerGene Therapeutics Business Overview
10.6.5 SynerGene Therapeutics Recent Developments
10.7 Altor BioScience
10.7.1 Altor BioScience Cancer Gene Therapy Basic Information
10.7.2 Altor BioScience Cancer Gene Therapy Product Overview
10.7.3 Altor BioScience Cancer Gene Therapy Product Market Performance
10.7.4 Altor BioScience Business Overview
10.7.5 Altor BioScience Recent Developments
10.8 Amgen
10.8.1 Amgen Cancer Gene Therapy Basic Information
10.8.2 Amgen Cancer Gene Therapy Product Overview
10.8.3 Amgen Cancer Gene Therapy Product Market Performance
10.8.4 Amgen Business Overview
10.8.5 Amgen Recent Developments
10.9 Argenx
10.9.1 Argenx Cancer Gene Therapy Basic Information
10.9.2 Argenx Cancer Gene Therapy Product Overview
10.9.3 Argenx Cancer Gene Therapy Product Market Performance
10.9.4 Argenx Business Overview
10.9.5 Argenx Recent Developments
10.10 BioCancell
10.10.1 BioCancell Cancer Gene Therapy Basic Information
10.10.2 BioCancell Cancer Gene Therapy Product Overview
10.10.3 BioCancell Cancer Gene Therapy Product Market Performance
10.10.4 BioCancell Business Overview
10.10.5 BioCancell Recent Developments
10.11 GlaxoSmithKline
10.11.1 GlaxoSmithKline Cancer Gene Therapy Basic Information
10.11.2 GlaxoSmithKline Cancer Gene Therapy Product Overview
10.11.3 GlaxoSmithKline Cancer Gene Therapy Product Market Performance
10.11.4 GlaxoSmithKline Business Overview
10.11.5 GlaxoSmithKline Recent Developments
10.12 Merck
10.12.1 Merck Cancer Gene Therapy Basic Information
10.12.2 Merck Cancer Gene Therapy Product Overview
10.12.3 Merck Cancer Gene Therapy Product Market Performance
10.12.4 Merck Business Overview
10.12.5 Merck Recent Developments
10.13 OncoGenex Pharmaceuticals
10.13.1 OncoGenex Pharmaceuticals Cancer Gene Therapy Basic Information
10.13.2 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Overview
10.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Market Performance
10.13.4 OncoGenex Pharmaceuticals Business Overview
10.13.5 OncoGenex Pharmaceuticals Recent Developments
10.14 Transgene
10.14.1 Transgene Cancer Gene Therapy Basic Information
10.14.2 Transgene Cancer Gene Therapy Product Overview
10.14.3 Transgene Cancer Gene Therapy Product Market Performance
10.14.4 Transgene Business Overview
10.14.5 Transgene Recent Developments
11 CANCER GENE THERAPY MARKET FORECAST BY REGION
11.1 Global Cancer Gene Therapy Market Size Forecast
11.2 Global Cancer Gene Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cancer Gene Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Cancer Gene Therapy Market Size Forecast by Region
11.2.4 South America Cancer Gene Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Cancer Gene Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Cancer Gene Therapy Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Cancer Gene Therapy by Type (2025-2032)
12.1.2 Global Cancer Gene Therapy Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Cancer Gene Therapy by Type (2025-2032)
12.2 Global Cancer Gene Therapy Market Forecast by Application (2025-2032)
12.2.1 Global Cancer Gene Therapy Sales (K Units) Forecast by Application
12.2.2 Global Cancer Gene Therapy Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cancer Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Cancer Gene Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cancer Gene Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cancer Gene Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cancer Gene Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2022)
Table 10. Global Market Cancer Gene Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cancer Gene Therapy Sales Sites and Area Served
Table 12. Manufacturers Cancer Gene Therapy Product Type
Table 13. Global Cancer Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cancer Gene Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cancer Gene Therapy Market Challenges
Table 22. Global Cancer Gene Therapy Sales by Type (K Units)
Table 23. Global Cancer Gene Therapy Market Size by Type (M USD)
Table 24. Global Cancer Gene Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Cancer Gene Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Cancer Gene Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Cancer Gene Therapy Market Size Share by Type (2019-2024)
Table 28. Global Cancer Gene Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cancer Gene Therapy Sales (K Units) by Application
Table 30. Global Cancer Gene Therapy Market Size by Application
Table 31. Global Cancer Gene Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Cancer Gene Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Cancer Gene Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Cancer Gene Therapy Market Share by Application (2019-2024)
Table 35. Global Cancer Gene Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Cancer Gene Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Cancer Gene Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Cancer Gene Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cancer Gene Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cancer Gene Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Cancer Gene Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cancer Gene Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Global Cancer Gene Therapy Production (K Units) by Region (2019-2024)
Table 44. Global Cancer Gene Therapy Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Cancer Gene Therapy Revenue Market Share by Region (2019-2024)
Table 46. Global Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Adaptimmune Cancer Gene Therapy Basic Information
Table 52. Adaptimmune Cancer Gene Therapy Product Overview
Table 53. Adaptimmune Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Adaptimmune Business Overview
Table 55. Adaptimmune Cancer Gene Therapy SWOT Analysis
Table 56. Adaptimmune Recent Developments
Table 57. Bluebird bio Cancer Gene Therapy Basic Information
Table 58. Bluebird bio Cancer Gene Therapy Product Overview
Table 59. Bluebird bio Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Bluebird bio Business Overview
Table 61. Bluebird bio Cancer Gene Therapy SWOT Analysis
Table 62. Bluebird bio Recent Developments
Table 63. Celgene Cancer Gene Therapy Basic Information
Table 64. Celgene Cancer Gene Therapy Product Overview
Table 65. Celgene Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Celgene Cancer Gene Therapy SWOT Analysis
Table 67. Celgene Business Overview
Table 68. Celgene Recent Developments
Table 69. Shanghai Sunway Biotech Cancer Gene Therapy Basic Information
Table 70. Shanghai Sunway Biotech Cancer Gene Therapy Product Overview
Table 71. Shanghai Sunway Biotech Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Shanghai Sunway Biotech Business Overview
Table 73. Shanghai Sunway Biotech Recent Developments
Table 74. Shenzhen SiBiono GeneTech Cancer Gene Therapy Basic Information
Table 75. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Overview
Table 76. Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Shenzhen SiBiono GeneTech Business Overview
Table 78. Shenzhen SiBiono GeneTech Recent Developments
Table 79. SynerGene Therapeutics Cancer Gene Therapy Basic Information
Table 80. SynerGene Therapeutics Cancer Gene Therapy Product Overview
Table 81. SynerGene Therapeutics Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. SynerGene Therapeutics Business Overview
Table 83. SynerGene Therapeutics Recent Developments
Table 84. Altor BioScience Cancer Gene Therapy Basic Information
Table 85. Altor BioScience Cancer Gene Therapy Product Overview
Table 86. Altor BioScience Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Altor BioScience Business Overview
Table 88. Altor BioScience Recent Developments
Table 89. Amgen Cancer Gene Therapy Basic Information
Table 90. Amgen Cancer Gene Therapy Product Overview
Table 91. Amgen Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Amgen Business Overview
Table 93. Amgen Recent Developments
Table 94. Argenx Cancer Gene Therapy Basic Information
Table 95. Argenx Cancer Gene Therapy Product Overview
Table 96. Argenx Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Argenx Business Overview
Table 98. Argenx Recent Developments
Table 99. BioCancell Cancer Gene Therapy Basic Information
Table 100. BioCancell Cancer Gene Therapy Product Overview
Table 101. BioCancell Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. BioCancell Business Overview
Table 103. BioCancell Recent Developments
Table 104. GlaxoSmithKline Cancer Gene Therapy Basic Information
Table 105. GlaxoSmithKline Cancer Gene Therapy Product Overview
Table 106. GlaxoSmithKline Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. GlaxoSmithKline Business Overview
Table 108. GlaxoSmithKline Recent Developments
Table 109. Merck Cancer Gene Therapy Basic Information
Table 110. Merck Cancer Gene Therapy Product Overview
Table 111. Merck Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Merck Business Overview
Table 113. Merck Recent Developments
Table 114. OncoGenex Pharmaceuticals Cancer Gene Therapy Basic Information
Table 115. OncoGenex Pharmaceuticals Cancer Gene Therapy Product Overview
Table 116. OncoGenex Pharmaceuticals Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. OncoGenex Pharmaceuticals Business Overview
Table 118. OncoGenex Pharmaceuticals Recent Developments
Table 119. Transgene Cancer Gene Therapy Basic Information
Table 120. Transgene Cancer Gene Therapy Product Overview
Table 121. Transgene Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Transgene Business Overview
Table 123. Transgene Recent Developments
Table 124. Global Cancer Gene Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 125. Global Cancer Gene Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 126. North America Cancer Gene Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 127. North America Cancer Gene Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 128. Europe Cancer Gene Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 129. Europe Cancer Gene Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 130. Asia Pacific Cancer Gene Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 131. Asia Pacific Cancer Gene Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 132. South America Cancer Gene Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 133. South America Cancer Gene Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 134. Middle East and Africa Cancer Gene Therapy Consumption Forecast by Country (2025-2032) & (Units)
Table 135. Middle East and Africa Cancer Gene Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 136. Global Cancer Gene Therapy Sales Forecast by Type (2025-2032) & (K Units)
Table 137. Global Cancer Gene Therapy Market Size Forecast by Type (2025-2032) & (M USD)
Table 138. Global Cancer Gene Therapy Price Forecast by Type (2025-2032) & (USD/Unit)
Table 139. Global Cancer Gene Therapy Sales (K Units) Forecast by Application (2025-2032)
Table 140. Global Cancer Gene Therapy Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cancer Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Cancer Gene Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cancer Gene Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cancer Gene Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cancer Gene Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2022)
Table 10. Global Market Cancer Gene Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cancer Gene Therapy Sales Sites and Area Served
Table 12. Manufacturers Cancer Gene Therapy Product Type
Table 13. Global Cancer Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cancer Gene Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cancer Gene Therapy Market Challenges
Table 22. Global Cancer Gene Therapy Sales by Type (K Units)
Table 23. Global Cancer Gene Therapy Market Size by Type (M USD)
Table 24. Global Cancer Gene Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Cancer Gene Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Cancer Gene Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Cancer Gene Therapy Market Size Share by Type (2019-2024)
Table 28. Global Cancer Gene Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cancer Gene Therapy Sales (K Units) by Application
Table 30. Global Cancer Gene Therapy Market Size by Application
Table 31. Global Cancer Gene Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Cancer Gene Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Cancer Gene Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Cancer Gene Therapy Market Share by Application (2019-2024)
Table 35. Global Cancer Gene Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Cancer Gene Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Cancer Gene Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Cancer Gene Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cancer Gene Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cancer Gene Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Cancer Gene Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cancer Gene Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Global Cancer Gene Therapy Production (K Units) by Region (2019-2024)
Table 44. Global Cancer Gene Therapy Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Cancer Gene Therapy Revenue Market Share by Region (2019-2024)
Table 46. Global Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Adaptimmune Cancer Gene Therapy Basic Information
Table 52. Adaptimmune Cancer Gene Therapy Product Overview
Table 53. Adaptimmune Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Adaptimmune Business Overview
Table 55. Adaptimmune Cancer Gene Therapy SWOT Analysis
Table 56. Adaptimmune Recent Developments
Table 57. Bluebird bio Cancer Gene Therapy Basic Information
Table 58. Bluebird bio Cancer Gene Therapy Product Overview
Table 59. Bluebird bio Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Bluebird bio Business Overview
Table 61. Bluebird bio Cancer Gene Therapy SWOT Analysis
Table 62. Bluebird bio Recent Developments
Table 63. Celgene Cancer Gene Therapy Basic Information
Table 64. Celgene Cancer Gene Therapy Product Overview
Table 65. Celgene Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Celgene Cancer Gene Therapy SWOT Analysis
Table 67. Celgene Business Overview
Table 68. Celgene Recent Developments
Table 69. Shanghai Sunway Biotech Cancer Gene Therapy Basic Information
Table 70. Shanghai Sunway Biotech Cancer Gene Therapy Product Overview
Table 71. Shanghai Sunway Biotech Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Shanghai Sunway Biotech Business Overview
Table 73. Shanghai Sunway Biotech Recent Developments
Table 74. Shenzhen SiBiono GeneTech Cancer Gene Therapy Basic Information
Table 75. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Overview
Table 76. Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Shenzhen SiBiono GeneTech Business Overview
Table 78. Shenzhen SiBiono GeneTech Recent Developments
Table 79. SynerGene Therapeutics Cancer Gene Therapy Basic Information
Table 80. SynerGene Therapeutics Cancer Gene Therapy Product Overview
Table 81. SynerGene Therapeutics Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. SynerGene Therapeutics Business Overview
Table 83. SynerGene Therapeutics Recent Developments
Table 84. Altor BioScience Cancer Gene Therapy Basic Information
Table 85. Altor BioScience Cancer Gene Therapy Product Overview
Table 86. Altor BioScience Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Altor BioScience Business Overview
Table 88. Altor BioScience Recent Developments
Table 89. Amgen Cancer Gene Therapy Basic Information
Table 90. Amgen Cancer Gene Therapy Product Overview
Table 91. Amgen Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Amgen Business Overview
Table 93. Amgen Recent Developments
Table 94. Argenx Cancer Gene Therapy Basic Information
Table 95. Argenx Cancer Gene Therapy Product Overview
Table 96. Argenx Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Argenx Business Overview
Table 98. Argenx Recent Developments
Table 99. BioCancell Cancer Gene Therapy Basic Information
Table 100. BioCancell Cancer Gene Therapy Product Overview
Table 101. BioCancell Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. BioCancell Business Overview
Table 103. BioCancell Recent Developments
Table 104. GlaxoSmithKline Cancer Gene Therapy Basic Information
Table 105. GlaxoSmithKline Cancer Gene Therapy Product Overview
Table 106. GlaxoSmithKline Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. GlaxoSmithKline Business Overview
Table 108. GlaxoSmithKline Recent Developments
Table 109. Merck Cancer Gene Therapy Basic Information
Table 110. Merck Cancer Gene Therapy Product Overview
Table 111. Merck Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Merck Business Overview
Table 113. Merck Recent Developments
Table 114. OncoGenex Pharmaceuticals Cancer Gene Therapy Basic Information
Table 115. OncoGenex Pharmaceuticals Cancer Gene Therapy Product Overview
Table 116. OncoGenex Pharmaceuticals Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. OncoGenex Pharmaceuticals Business Overview
Table 118. OncoGenex Pharmaceuticals Recent Developments
Table 119. Transgene Cancer Gene Therapy Basic Information
Table 120. Transgene Cancer Gene Therapy Product Overview
Table 121. Transgene Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Transgene Business Overview
Table 123. Transgene Recent Developments
Table 124. Global Cancer Gene Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 125. Global Cancer Gene Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 126. North America Cancer Gene Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 127. North America Cancer Gene Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 128. Europe Cancer Gene Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 129. Europe Cancer Gene Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 130. Asia Pacific Cancer Gene Therapy Sales Forecast by Region (2025-2032) & (K Units)
Table 131. Asia Pacific Cancer Gene Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 132. South America Cancer Gene Therapy Sales Forecast by Country (2025-2032) & (K Units)
Table 133. South America Cancer Gene Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 134. Middle East and Africa Cancer Gene Therapy Consumption Forecast by Country (2025-2032) & (Units)
Table 135. Middle East and Africa Cancer Gene Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 136. Global Cancer Gene Therapy Sales Forecast by Type (2025-2032) & (K Units)
Table 137. Global Cancer Gene Therapy Market Size Forecast by Type (2025-2032) & (M USD)
Table 138. Global Cancer Gene Therapy Price Forecast by Type (2025-2032) & (USD/Unit)
Table 139. Global Cancer Gene Therapy Sales (K Units) Forecast by Application (2025-2032)
Table 140. Global Cancer Gene Therapy Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cancer Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cancer Gene Therapy Market Size (M USD), 2019-2032
Figure 5. Global Cancer Gene Therapy Market Size (M USD) (2019-2032)
Figure 6. Global Cancer Gene Therapy Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cancer Gene Therapy Market Size by Country (M USD)
Figure 11. Cancer Gene Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Cancer Gene Therapy Revenue Share by Manufacturers in 2023
Figure 13. Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cancer Gene Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cancer Gene Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cancer Gene Therapy Market Share by Type
Figure 18. Sales Market Share of Cancer Gene Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Cancer Gene Therapy by Type in 2023
Figure 20. Market Size Share of Cancer Gene Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Cancer Gene Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cancer Gene Therapy Market Share by Application
Figure 24. Global Cancer Gene Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Cancer Gene Therapy Sales Market Share by Application in 2023
Figure 26. Global Cancer Gene Therapy Market Share by Application (2019-2024)
Figure 27. Global Cancer Gene Therapy Market Share by Application in 2023
Figure 28. Global Cancer Gene Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cancer Gene Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cancer Gene Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cancer Gene Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cancer Gene Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cancer Gene Therapy Sales Market Share by Country in 2023
Figure 37. Germany Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cancer Gene Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cancer Gene Therapy Sales Market Share by Region in 2023
Figure 44. China Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cancer Gene Therapy Sales and Growth Rate (K Units)
Figure 50. South America Cancer Gene Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cancer Gene Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cancer Gene Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cancer Gene Therapy Production Market Share by Region (2019-2024)
Figure 62. North America Cancer Gene Therapy Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Cancer Gene Therapy Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Cancer Gene Therapy Production (K Units) Growth Rate (2019-2024)
Figure 65. China Cancer Gene Therapy Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Cancer Gene Therapy Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Cancer Gene Therapy Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Cancer Gene Therapy Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Cancer Gene Therapy Market Share Forecast by Type (2025-2032)
Figure 70. Global Cancer Gene Therapy Sales Forecast by Application (2025-2032)
Figure 71. Global Cancer Gene Therapy Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Cancer Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cancer Gene Therapy Market Size (M USD), 2019-2032
Figure 5. Global Cancer Gene Therapy Market Size (M USD) (2019-2032)
Figure 6. Global Cancer Gene Therapy Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cancer Gene Therapy Market Size by Country (M USD)
Figure 11. Cancer Gene Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Cancer Gene Therapy Revenue Share by Manufacturers in 2023
Figure 13. Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cancer Gene Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cancer Gene Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cancer Gene Therapy Market Share by Type
Figure 18. Sales Market Share of Cancer Gene Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Cancer Gene Therapy by Type in 2023
Figure 20. Market Size Share of Cancer Gene Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Cancer Gene Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cancer Gene Therapy Market Share by Application
Figure 24. Global Cancer Gene Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Cancer Gene Therapy Sales Market Share by Application in 2023
Figure 26. Global Cancer Gene Therapy Market Share by Application (2019-2024)
Figure 27. Global Cancer Gene Therapy Market Share by Application in 2023
Figure 28. Global Cancer Gene Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cancer Gene Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cancer Gene Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cancer Gene Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cancer Gene Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cancer Gene Therapy Sales Market Share by Country in 2023
Figure 37. Germany Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cancer Gene Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cancer Gene Therapy Sales Market Share by Region in 2023
Figure 44. China Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cancer Gene Therapy Sales and Growth Rate (K Units)
Figure 50. South America Cancer Gene Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cancer Gene Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cancer Gene Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cancer Gene Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cancer Gene Therapy Production Market Share by Region (2019-2024)
Figure 62. North America Cancer Gene Therapy Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Cancer Gene Therapy Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Cancer Gene Therapy Production (K Units) Growth Rate (2019-2024)
Figure 65. China Cancer Gene Therapy Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Cancer Gene Therapy Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Cancer Gene Therapy Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Cancer Gene Therapy Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Cancer Gene Therapy Market Share Forecast by Type (2025-2032)
Figure 70. Global Cancer Gene Therapy Sales Forecast by Application (2025-2032)
Figure 71. Global Cancer Gene Therapy Market Share Forecast by Application (2025-2032)
